TWIST BIOSCIENCE CORP
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$376.57M
Revenue
$-77.67M
Net Income
-1.31
EPS (Diluted)
$-140.15M
Free Cash Flow
Profitability
Gross Margin
50.72%
Operating Margin
-36.18%
Net Profit Margin
-20.63%
EBITDA
$-92.24M
Returns & Efficiency
Return on Assets (ROA)
-12.10%
Return on Equity (ROE)
-16.42%
Gross Profit
$191.00M
Operating Income
$-136.26M
Financial Health
Total Assets
$641.86M
Total Debt
-
Debt to Equity
0.36x
Current Ratio
3.64
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-1.31
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080 |
| Phone | 800-719-0671 |
| Incorporated | DE, US |
| EIN | 462058888 |
| Fiscal Year End | 0930 |
| Shares Outstanding | 208,000.00 |
| Stockholders' Equity | $472.96M |
| Cash & Equivalents | $183.05M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
10-Q/A
Amended Quarterly Report
Amendment to previously filed quarterly report
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-25
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-23
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-23
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-23
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-23
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
50.7%
Operating Margin
-36.2%
Net Margin
-20.6%
ROE
-16.4%
ROA
-12.1%
Leverage & Liquidity
Debt to Equity
0.36
Current Ratio
3.64
Total Debt
-
Total Assets
$641.86M
Stockholders' Equity
$472.96M
Income Statement (FY 2025)
Revenue
$376.57M
Gross Profit
$191.00M
Operating Income
$-136.26M
Net Income
$-77.67M
EPS (Diluted)
$-1.31
Cash Flow (FY 2025)
Free Cash Flow
$-140.15M
Cash & Equivalents
$183.05M
Revenue Growth
20.3%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...